🇺🇸 FDA
Pipeline program

aspirin and clopidogrel

2022-SR-228

Approved small_molecule active

Quick answer

aspirin and clopidogrel for Atrial Fibrillation is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Atrial Fibrillation
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials